These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6479221)

  • 1. Long-lasting behavioral effects of bromocriptine in cats.
    Gonzalez-Lima F; Stiehl WL; Medina R
    Eur J Pharmacol; 1984 Jul; 102(2):279-87. PubMed ID: 6479221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to the behavioral effects of bromocriptine in cats.
    Gonzalez-Lima F; Stiehl WL; Ocasio H
    Eur J Pharmacol; 1984 Jul; 102(2):289-95. PubMed ID: 6541142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of behavioral effects of bromocriptine by prolactin in female cats.
    Gonzalez-Lima F; Velez D; Blanco R
    Behav Neural Biol; 1988 Jan; 49(1):74-82. PubMed ID: 3345193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite involvement in the behavioral effects of bromocriptine in cats.
    Gonzalez-Lima F; Hart WT; Rivera-Quinones C
    Eur J Pharmacol; 1987 Sep; 141(1):109-15. PubMed ID: 3666021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.
    Jacobs BL; Trulson ME; Stern WC
    Brain Res; 1977 Aug; 132(2):301-14. PubMed ID: 19128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of the behavioral effects of lysergic acid diethylamide in cats.
    Trulson ME; Howell GA
    Dev Psychobiol; 1984 Jul; 17(4):329-46. PubMed ID: 6745496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of a non-hallucinogenic ergoline derivative, lisuride, in an animal behavior model for hallucinogens.
    Marini JL; Jacobs BL; Sheard MH; Trulson ME
    Psychopharmacology (Berl); 1981; 73(4):328-31. PubMed ID: 6789353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An animal behavior model for studying the actions of LSD and related hallucinogens.
    Jacobs BL; Trulson ME; Stern WC
    Science; 1976 Nov; 194(4266):741-3. PubMed ID: 982043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of quipazine in the cat.
    Trulson ME; Brandstetter JW; Crisp T; Jacobs BL
    Eur J Pharmacol; 1982 Mar; 78(3):295-305. PubMed ID: 6461558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of an animal behavioral model in studying the duration of action of LSD and the onset and duration of tolerance to LSD in the cat.
    Trulson ME; Jacobs BL
    Brain Res; 1977 Aug; 132(2):315-26. PubMed ID: 890483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LSD acts synergistically with serotonin depletion: evidence from behavioral studies in cats.
    Trulson ME; Jacobs BL
    Pharmacol Biochem Behav; 1976 Mar; 4(3):231-4. PubMed ID: 132670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of apomorphine in the cat.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1982 Jun; 80(4):295-309. PubMed ID: 6213419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance develops to LSD while the drug is exerting its maximal behavioral effects: implications for the neural bases of tolerance.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1983 Dec; 96(3-4):317-20. PubMed ID: 6676109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of tolerance to the behavioral effects of LSD from changes in serotonin receptor binding in cats.
    Trulson ME
    Eur J Pharmacol; 1985 May; 111(3):385-8. PubMed ID: 4018133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of serotonergic and dopaminergic drugs in cats following chronic amphetamine administration.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1984 Apr; 99(4):313-24. PubMed ID: 6734730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of specificity of an animal behavior model for hallucinogenic drug action.
    White FJ; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1981 Mar; 14(3):339-43. PubMed ID: 7232460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological and behavioral effects of 1-methyl-5-(o-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one (ID-540) in cats and rabbits.
    Otsuka M; Tsuchiya T; Kitagawa S
    Arzneimittelforschung; 1975 May; 25(5):755-60. PubMed ID: 1242317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
    Trulson ME; Preussler DW; Trulson VM
    J Pharmacol Exp Ther; 1984 Jan; 228(1):94-102. PubMed ID: 6694110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the specificity of a cat behavior model for the study of hallucinogens.
    Marini JL; Sheard MH
    Eur J Pharmacol; 1981 Apr; 70(4):479-87. PubMed ID: 7238573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.